Evidence map›Paper›PMID 10364520›Full record

ArticleAmerican journal of human genetics1999

MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications.

C Cazeneuve, T Sarkisian, C Pêcheux, M Dervichian, B Nédelec, P Reinert, A Ayvazyan, J C Kouyoumdjian, H Ajrapetyan, M Delpech and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 259 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. An Update on Familial Mediterranean Fever.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Secondary Amyloidosis Presenting as Ischemic Proctitis.Case reports in gastrointestinal medicine · 2021
    Article
  16. Clinical and genetic heterogeneity in a large cohort of Armenian patients with late-onset familial Mediterranean fever.Genetics in medicine : official journal of the American College of Medical Genetics · 2018
    Article
  17. ProbioticFrontiers in immunology · 2018
    Article
  18. Review
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 2 countries.

C Cazeneuve1Service de Biochimie et de Génétique Moléculaire and the Institut National de la Santé et de la Recherche Médicale (Unité 468), Hôpital, Mondor, France.
T Sarkisian
C Pêcheux
M Dervichian
B Nédelec
P Reinert
A Ayvazyan
J C Kouyoumdjian
H Ajrapetyan
M Delpech
M Goossens
C Dodé
G Grateau
S Amselem
Hôpital Cochin · FRInserm · FRYerevan State University · AMCentre Hospitalier Intercommunal de Villeneuve-Saint-Georges · FRErebouni Medical Center · AMHôpital Intercommunal de Créteil · FRHôtel-Dieu de Paris · FRInstitut de Biochimie et Biophysique Moléculaire et Cellulaire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Familial Mediterranean fever (FMF) is a recessively inherited disorder that is common in patients of Armenian ancestry. To date, its diagnosis, which can be made only retrospectively, is one of exclusion, based entirely on nonspecific clinical signs that result from serosal inflammation and that may lead to unnecessary surgery. Renal amyloidosis, prevented by colchicine, is the most severe complication of FMF, a disorder associated with mutations in the MEFV gene. To evaluate the diagnostic and prognostic value of MEFV-gene analysis, we investigated 90 Armenian FMF patients from 77 unrelated families that were not selected through genetic-linkage analysis. Eight mutations, one of which (R408Q) is new, were found to account for 93% of the 163 independent FMF alleles, with both FMF alleles identified in 89% of the patients. In several instances, family studies provided molecular evidence for pseudodominant transmission and incomplete penetrance of the disease phenotype. The M694V homozygous genotype was found to be associated with a higher prevalence of renal amyloidosis and arthritis, compared with other genotypes (P=.0002 and P=.006, respectively). The demonstration of both the diagnostic and prognostic value of MEFV analysis and particular modes of inheritance should lead to new ways for management of FMF-including genetic counseling and therapeutic decisions in affected families.

Indexed as

AdolescentAdultArmeniaChildChild, PreschoolColchicineCytoskeletal ProteinsFamilial Mediterranean FeverFemaleGenetic TestingGenotypeGout SuppressantsHumansKidney DiseasesMaleMiddle AgedColchicineCytoskeletal ProteinsGout SuppressantsMEFV protein, humanProteinsPyrin

Identifiers

PMID10364520
PMCPMC1378078
OpenAlexW2001747858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.